EP2150243A4 - Compositions et procédés d'amélioration de l'absorption d'agents actifs - Google Patents
Compositions et procédés d'amélioration de l'absorption d'agents actifsInfo
- Publication number
- EP2150243A4 EP2150243A4 EP08755962.1A EP08755962A EP2150243A4 EP 2150243 A4 EP2150243 A4 EP 2150243A4 EP 08755962 A EP08755962 A EP 08755962A EP 2150243 A4 EP2150243 A4 EP 2150243A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- active agent
- agent absorption
- enhancing active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/805,202 US8426466B2 (en) | 2006-05-22 | 2007-05-21 | Compositions and methods for enhancing active agent absorption |
US409907P | 2007-11-21 | 2007-11-21 | |
PCT/US2008/064233 WO2008144690A2 (fr) | 2007-05-21 | 2008-05-20 | Compositions et procédés d'amélioration de l'absorption d'agents actifs |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2150243A2 EP2150243A2 (fr) | 2010-02-10 |
EP2150243A4 true EP2150243A4 (fr) | 2013-08-21 |
Family
ID=40122287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08755962.1A Withdrawn EP2150243A4 (fr) | 2007-05-21 | 2008-05-20 | Compositions et procédés d'amélioration de l'absorption d'agents actifs |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2150243A4 (fr) |
WO (1) | WO2008144690A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906592B (zh) * | 2011-02-25 | 2017-11-03 | 广州南沙龙沙有限公司 | 用于蛋白质药物偶联物的支链联接体 |
US9796962B2 (en) | 2013-08-07 | 2017-10-24 | Kyoto University | Method for generating pancreatic hormone-producing cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817624A (en) * | 1995-06-05 | 1998-10-06 | Alza Corporation | Permeation enhancer compositions for increased absorption of therapeutic proteins through the colonic membrane |
IL150818A0 (en) * | 2000-01-27 | 2003-02-12 | Aqua Solution Inc | Composition for intestinal delivery |
US20030198666A1 (en) * | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
CN100522243C (zh) * | 2006-03-13 | 2009-08-05 | 新疆维吾尔自治区畜牧科学院兽医研究所 | 动物皮肤渗透剂 |
-
2008
- 2008-05-20 EP EP08755962.1A patent/EP2150243A4/fr not_active Withdrawn
- 2008-05-20 WO PCT/US2008/064233 patent/WO2008144690A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
Non-Patent Citations (4)
Title |
---|
FAUST JOHN A ET AL: "Derivatives of salicylamide", AMERICAN PHARMACEUTICAL ASSOCIATION. JOURNAL, AMERICAN PHARMACISTS ASSOCIATION, US, vol. 45, no. 8, 20 February 1956 (1956-02-20), pages 514 - 517, XP008115755, ISSN: 0003-0465, [retrieved on 20060923], DOI: 10.1002/JPS.3030450803 * |
NAITO MASUKAZU ET AL: "Chemotherapeutics for Mycobacterium tuberculosis. XII. Antibacterial activity of derivatives of esters of p-aminosalicylic acid on Mycobacterium tuberculosis", YAKUGAKU ZASSHI, PHARMACEUTICAL SOCIETY OF JAPAN, JP, vol. 78, no. 6, 1 January 1958 (1958-01-01), pages 682 - 683, XP008115756, ISSN: 0031-6903 * |
See also references of WO2008144690A2 * |
XUAN DING ET AL: "Oral Absorption Enhancement of Cromolyn Sodium Through Noncovalent Complexation", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, vol. 21, no. 12, 1 December 2004 (2004-12-01), pages 2196 - 2206, XP019370659, ISSN: 1573-904X, DOI: 10.1007/S11095-004-7671-9 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008144690A3 (fr) | 2009-02-26 |
WO2008144690A2 (fr) | 2008-11-27 |
EP2150243A2 (fr) | 2010-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1145339A1 (zh) | 用於定向整合的方法和組合物 | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
ZA201001300B (en) | Antigen-asjuvant compositions and methods | |
EP2398466A4 (fr) | Procédés et compositions pour la délivrance localisée d agents | |
EP2330171A4 (fr) | Composition d'agent absorbant l'uv | |
HK1137670A1 (en) | Compositions and methods for arthrodetic procedures | |
EP2327750A4 (fr) | Composition d'adhésif et agent adhésif la comprenant | |
EP2079544A4 (fr) | Composition absorbant l'arsenic et procédés d'utilisation | |
EP2012806A4 (fr) | Procédés et compositions permettant de modifier la fonction cellulaire | |
EP2101731A4 (fr) | Procédés et compositions d'endoxifène | |
ZA200900140B (en) | Methods and compositions for treating biofilms | |
IL194826A0 (en) | Compositions and methods for cellular imaging and therapy | |
GB0721291D0 (en) | Methods and compositions | |
EP2088865A4 (fr) | Procédés et compositions autour de guggulphospholipides | |
PL2061458T3 (pl) | Kompozycje topiramatu i sposoby ich stosowania | |
GB0719526D0 (en) | Compositions and methods | |
GB0612784D0 (en) | Compound, composition and use | |
EP2030629A4 (fr) | Agent d'amélioration du métabolisme des lipides | |
EP2060263A4 (fr) | Agent d'amélioration du métabolisme lipidique | |
HK1155062A1 (en) | Pharmaceutical composition and combined agent | |
EP2150243A4 (fr) | Compositions et procédés d'amélioration de l'absorption d'agents actifs | |
IL194689A0 (en) | Agent, composition and method | |
LT2231171T (lt) | Kompozicijos ir būdai, skirti geležies absorbcijos padidinimui | |
GB2461611B (en) | Composition and use thereof | |
GB0920151D0 (en) | Contrast agent compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20091123 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130724 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 47/10 20060101ALI20130718BHEP Ipc: A61K 9/00 20060101ALI20130718BHEP Ipc: A61K 38/16 20060101AFI20130718BHEP Ipc: A61K 47/18 20060101ALI20130718BHEP Ipc: A61K 31/715 20060101ALI20130718BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20151201 |